Antigenic structure of chimeras of type 1 and type 3 poliovirus involving antigenic site 1. 1990

P D Minor, and M Ferguson, and K Katrak, and D Wood, and A John, and J Howlett, and G Dunn, and K Burke, and J W Almond
National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, U.K.

Chimeric polioviruses have been prepared in which part of the antigenic site 1-encoding sequence of the Sabin strain of type 1 poliovirus has been replaced by sequences based on those found in the homologous region of the Sabin type 3 strain. The chimeras were analysed for their reaction with polyclonal and monoclonal antibodies raised against type 1 and type 3 viruses, and with polyclonal antipeptide sera, as well as for their immunogenicity in animals. The effectiveness with which the type 3 site was presented antigenically varied in ways which were partially predictable, based on the behaviour of type 3 mutants with monoclonal antibodies. However, other factors were implicated which may include conformational effects and other components of the site in addition to those altered in the chimeras. The ability of the chimeras to induce antibodies reacting with type 3 polioviruses paralleled their antigenic reactivity, and evidence is presented for the induction of strain-specific antibodies.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011055 Poliovirus Vaccine, Oral A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed) Sabin Vaccine,Oral Poliovirus Vaccine,Vaccine, Oral Poliovirus,Vaccine, Sabin
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D002678 Chimera An individual that contains cell populations derived from different zygotes. Hybrids,Chimeras,Hybrid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic

Related Publications

P D Minor, and M Ferguson, and K Katrak, and D Wood, and A John, and J Howlett, and G Dunn, and K Burke, and J W Almond
May 1988, Journal of virology,
P D Minor, and M Ferguson, and K Katrak, and D Wood, and A John, and J Howlett, and G Dunn, and K Burke, and J W Almond
December 1989, Journal of virology,
P D Minor, and M Ferguson, and K Katrak, and D Wood, and A John, and J Howlett, and G Dunn, and K Burke, and J W Almond
May 1986, Microbiological sciences,
P D Minor, and M Ferguson, and K Katrak, and D Wood, and A John, and J Howlett, and G Dunn, and K Burke, and J W Almond
January 1981, Developments in biological standardization,
P D Minor, and M Ferguson, and K Katrak, and D Wood, and A John, and J Howlett, and G Dunn, and K Burke, and J W Almond
September 2022, The Journal of infectious diseases,
P D Minor, and M Ferguson, and K Katrak, and D Wood, and A John, and J Howlett, and G Dunn, and K Burke, and J W Almond
February 1991, Journal of virology,
P D Minor, and M Ferguson, and K Katrak, and D Wood, and A John, and J Howlett, and G Dunn, and K Burke, and J W Almond
January 1987, Microbiology and immunology,
P D Minor, and M Ferguson, and K Katrak, and D Wood, and A John, and J Howlett, and G Dunn, and K Burke, and J W Almond
March 1959, Journal of immunology (Baltimore, Md. : 1950),
P D Minor, and M Ferguson, and K Katrak, and D Wood, and A John, and J Howlett, and G Dunn, and K Burke, and J W Almond
May 1988, Proceedings of the National Academy of Sciences of the United States of America,
P D Minor, and M Ferguson, and K Katrak, and D Wood, and A John, and J Howlett, and G Dunn, and K Burke, and J W Almond
April 1991, The Journal of general virology,
Copied contents to your clipboard!